MarketReserchReports.biz has
recently announced the addition of a market study “
Biotherapeutics Cell Line Development Market : Global Industry
Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2022”
With
the increasing number of recombinant protein therapeutics gaining
approval by the U.S. Food and Drug Administration (FDA) annually,
there is an increase in the demand of cell lines for production of
these biotherapeutics. From 2006 to 2011 an average of 15 novel
recombinant protein therapeutics and in 2014, 11 novel recombinant
protein therapeutics have been approved by US FDA. About forty-seven
monoclonal antibody products have been approved in the U.S., Europe
and other global markets, of which over 60% were produced in
mammalian cell culture.
Moreover,
the rise in the geriatric population coupled with prevalence of
diseases is one of the major factors driving the demand for cell line
development for biotherapeutics. The increasing demand for monoclonal
antibodies across the globe boosts the market growth. In addition,
the increasing number of initiatives taken by the government of
various countries by funding the life science research and
development is expected to propel this market in coming years.
The
global biotherapeutics cell line development market is segmented by
process, by cell line development option and by geography. The market
by process segment has been sub-segmented as transfection and single
cell cloning. The single cell cloning market is further sub-segmented
by method into manual limited dilution cloning, FACS, ClonePix and
Others. The market by CLD option is segmented as In-house, outsource,
hybrid and do-it-yourself. The ClonePix accounted for the largest
market share of 37.4% in 2014. Geographically, the market has been
studied and estimated for five regions: North America, Europe, Asia
Pacific, Latin America, and Middle East & Africa.
View Full Report at:
http://www.marketresearchreports.biz/analysis/531402
The
market overview section of the report demonstrates major market
dynamics such as drivers, restraints, and opportunities that
influence the current and future status of the industry. The market
overview section includes market attractiveness analysis, by
geography, to provide a thorough analysis of the overall competitive
scenario in the global biotherapeutics cell line development market.
The market overview section of the report also includes the
qualitative and quantitative analysis of the competitive landscape.
Market
share analysis for FACS market is also provided in the market
overview section of the report for 2014 in terms of value (%). The
report also provides important recommendations for market players and
new entrants. These recommendations would enable existing market
players to expand their market shares and help new companies to
establish their presence in the biotherapeutics cell line development
market across the world. The report concludes with the company
profiles section, which includes key information about major players
in the market such as financial overview, business strategies, and
recent developments. Major players in this market are Becton
Dickinson & Company (U.S.), Beckman Coulter (U.S.), Boehringer
Ingelheim Group (Germany), Catalent Inc. (U.S.), CMC Biologics A/S
(Denmark), Lonza Group Ltd. (Switzerland), EMD Millipore (U.S.),
Partec (Sysmex Corporation) (Japan), ProBioGen AG (Germany), Selexis
SA (Germany), Sigma-Aldrich Co. LLC. (U.S.), Sony Biotechnology Inc.
(U.S.), and Thermo Fisher Scientific Inc. (U.S.).
Download Detail Report With
Complete TOC at:
http://www.marketresearchreports.biz/sample/sample/531402
The global biotherapeutics
cell line development market has been segmented as follows:
- Global Biotherapeutics Cell Line Development Market, by Process
- Transfection & Selection
- Single Cell Cloning
- Manual limited dilution cloning
- FACS
- ClonePix
- Others
- Global Biotherapeutics Cell Line Development Market, by CLD Option
- In-house
- Outsource
- Hybrid
- Do-It-Yourself (DIY)
- Global Medical Cameras and Microscopes Market, by Geography
- North America
- Europe
- Asia Pacific (APAC)
- Latin America (LATAM)
- Middle East & Africa
Browse
Our Press Releases by Prnewswire:
http://www.prnewswire.com/news/marketresearchreports.biz
Table Of Content
Chapter
1 Introduction
1.1
Report Description
1.2
Research Methodology
1.3
Market Segmentation
1.4
Assumptions
Chapter
2 Executive Summary
2.1
Market Snapshot: Global Biotherapeutics Cell Line Development Market
2.2
Comparative Analysis: Global Biotherapeutics Cell Line Development
Market, by Geography, 2014 & 2022
Chapter
3 Biotherapeutics Cell Line Development Market Overview
3.1
Introduction
3.2
Market Dynamics
3.2.1
Drivers
3.2.2
Restraints
3.2.3
Opportunities
About us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz
services are specially designed to save time and money for our
clients.
We
are a one stop solution for all your research needs, our main
offerings are syndicated research
reports,
custom research, subscription access and consulting services. We
serve all sizes and types
of
companies spanning across various industries.
Contact
Mr.
Nachiket
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
This comment has been removed by the author.
ReplyDeleteThanks for sharing such kind of post! I have gone through with your article, the data are given in a very good manner. I've gain in depth knowledge about cell line development.This is a really good blog wish more people would read this, you offer some really good suggestions on best development. Thanks for sharing! There’s also some big knowledge in this website that like to visit Biosero, Inc.
ReplyDelete